These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 23909452

  • 1. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
    Panidis D, Tziomalos K, Papadakis E, Chatzis P, Kandaraki EA, Tsourdi EA, Katsikis I.
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):432-8. PubMed ID: 23909452
    [Abstract] [Full Text] [Related]

  • 2. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).
    Vosnakis C, Georgopoulos NA, Rousso D, Mavromatidis G, Katsikis I, Roupas ND, Mamali I, Panidis D.
    Gynecol Endocrinol; 2013 Mar; 29(3):242-5. PubMed ID: 23194076
    [Abstract] [Full Text] [Related]

  • 3. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 4. Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.
    Koiou E, Tziomalos K, Katsikis I, Kandaraki EA, Kalaitzakis E, Delkos D, Vosnakis C, Panidis D.
    Gynecol Endocrinol; 2012 Jan; 28(1):20-4. PubMed ID: 21756081
    [Abstract] [Full Text] [Related]

  • 5. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
    [Abstract] [Full Text] [Related]

  • 6. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
    Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464
    [Abstract] [Full Text] [Related]

  • 7. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
    Spanos N, Tziomalos K, Macut D, Koiou E, Kandaraki EA, Delkos D, Tsourdi E, Panidis D.
    Obes Facts; 2012 Sep; 5(4):495-504. PubMed ID: 22854419
    [Abstract] [Full Text] [Related]

  • 8. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D, Hulchiy M, Calaby A, Nybacka Å, Byström B, Hirschberg AL.
    Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
    [Abstract] [Full Text] [Related]

  • 9. Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome.
    Koiou E, Tziomalos K, Katsikis I, Delkos D, Tsourdi EA, Panidis D.
    Hormones (Athens); 2013 Jul; 12(4):559-66. PubMed ID: 24457404
    [Abstract] [Full Text] [Related]

  • 10. Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
    Song J, Ruan X, Gu M, Wang L, Wang H, Mueck AO.
    Gynecol Endocrinol; 2018 May; 34(5):413-417. PubMed ID: 29172796
    [Abstract] [Full Text] [Related]

  • 11. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [Abstract] [Full Text] [Related]

  • 12. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
    Tzotzas T, Samara M, Constantinidis T, Tziomalos K, Krassas G.
    Angiology; 2007 Apr; 58(1):26-33. PubMed ID: 17351155
    [Abstract] [Full Text] [Related]

  • 13. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
    Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, Teede HJ.
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
    [Abstract] [Full Text] [Related]

  • 14. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.
    Nybacka Å, Carlström K, Fabri F, Hellström PM, Hirschberg AL.
    Fertil Steril; 2013 Oct; 100(4):1096-102. PubMed ID: 23876536
    [Abstract] [Full Text] [Related]

  • 15. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ.
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [Abstract] [Full Text] [Related]

  • 16. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
    Harrison CL, Stepto NK, Hutchison SK, Teede HJ.
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):351-7. PubMed ID: 21711376
    [Abstract] [Full Text] [Related]

  • 17. Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss.
    Ravn P, Haugen AG, Glintborg D.
    Minerva Endocrinol; 2013 Mar; 38(1):59-76. PubMed ID: 23435443
    [Abstract] [Full Text] [Related]

  • 18. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
    Kim JJ, Chae SJ, Choi YM, Hwang KR, Song SH, Yoon SH, Kim SM, Ku SY, Kim SH, Kim JG, Moon SY.
    Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
    [Abstract] [Full Text] [Related]

  • 19. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [Abstract] [Full Text] [Related]

  • 20. Benefit of Delayed Fertility Therapy With Preconception Weight Loss Over Immediate Therapy in Obese Women With PCOS.
    Legro RS, Dodson WC, Kunselman AR, Stetter CM, Kris-Etherton PM, Williams NI, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Diamond MP, Schlaff WD, Casson PR, Christman GM, Barnhart KT, Bates GW, Usadi R, Lucidi S, Baker V, Zhang H, Eisenberg E, Coutifaris C, Dokras A.
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2658-66. PubMed ID: 27172435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.